| [1] He L，He XY，Lim LP，et al. A microRNA component of the p53 tumour suppressor network[J]. Nature，2007，447 (7148)：1130–1134. [2] Tazawa H，Tsuchiya N，Izumiya M，et al. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in col human on cancer cells[J]. Proc Natl Acad Sci USA，2007，104 (39)：15472–15477. [3] Corney DC，Flesken-Nikitin A，Godwin AK，et al. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth[J]. Cancer Res，2007， 67 (18)：8433–8438. [4] Kumamoto K，Spillare EA，Fujita K，et al. Nutlin-3a activates p53 to both down-regulate inhibitor of growth 2 and up-regulate miR-34a，miR-34b，and miR-34c expression，and induce senescence[J]. Cancer Res，2008，68 (9)：3193–3203. [5] Yamakuchi M，Ferlito M，Lowenstein CJ. MiR-34a repression of SIRT1 regulates apoptosis[J]. Proc Natl Acad Sci USA，2008，105 (36)： 13421–13426. [6] Sun F，Fu HJ，Liu Q，et al. Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest[J]. FEBS Lett，2008， 582 (10)： 1564–1568. [7] Welch C，Chen Y，Stallings RL. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells[J]. Oncogene，2007，26 (34)：5017–5022. [8] Jurong Yang，Dapeng Chen，Yani He，et al. MiR-34 modulates Caenorhabditis elegans lifespa via repressing the autophagy gene atg9[J]. AGE，2011. doi：10.1007/s11357-011-9324-3. [9] Nan Liu，Michael Landreh，Kajia Cao，et al. The microRNA miR-34 modulates ageing and neurodegeneration in Drosophila[J]. LETTER， 2012，482 (7386)：519–523. [10] Rokhlin OW，Scheinker VS，Taghiyev AF，et al. MicroRNA-34 mediates AR-dependent p53-induced apoptosis in prostate cancer[J]. Cancer Biol Ther，2008，7 (8)：1288–1296. [11] Nora Bandi，Erik Vassella. MiR-34a and miR-15a/16 are co-regulated in nonsmall cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner[J]. Mol Cancer，2011， 10 (1)： 55–65. [12] Lodygin D，Tarasov V，Epanchintsev A，et al. Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer[J]. Cell Cycle，2008，7 (16)：2591–2600. [13] Toyota M，Suzuki H，Sasaki Y，et al. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer[J]. Cancer Res，2008，68 (11)： 4123–4132. [14] Ji Q，Hao X，Zhang M，et al. MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells[J]. PLoS ONE，2009， 4 (8)： e6816. [15] Hitoshi Yamazaki，Tsuyoshi Chijiwa，Yoshimasa Inoue，et al. Overexpression of the miR-34 family suppresses invasive growth of malignant melanoma with the wild-type p53 gene[J]. Exp Ther， 2012，3 (5)：793–796. [16] Norimitsu Tanakaa，Shinichi Toyookaa，Junichi Soha，et al. Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung Cancer[J]. Lung Cancer，2012，76 (1)：32–38. [17] Na Li，Hanjiang Fu，Yi Tie，et al. MiR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells[J]. Cancer Letters，2009，275 (1)： 44–53. [18] Corney DC，Hwang CI，Matoso A，et al. Frequent downregulation of miR-34 family in human ovarian cancers[J]. Clin Cancer Res，2010，16 (4)：1119–1128. [19] Soichiro Y，Sharanjot S，Shahana M，et al. MicroRNA- 34a suppresses malignant transformation by targeting c-Myc transcriptional complexes in human renal cell carcinoma[J]. Carcinogenesis， 2011，2 (33)：294–300. [20] 孙秀锦，黄铖铖，涂 彧，等. MiR-34在辐射损伤时对细胞周期的调控作用[J]. 苏州大学学报：医学版，2011，31(3)： 350–353. [21] Kato M，Paranjape T，Ullrich R，et al. Mir-34 microRNA is required for the DNA damage response in vivo in C. elegans and in vitro in human breast cancer cells[J]. Oncogene，2009，28 (25)：2419–2424. [22] 程 赢，和生辉，刘 聪，等. 辐射诱导性miR-34a 的表达对细胞辐射敏感性的影响[J]. 第二军医大学学报，2011，32 (4)：368–371. [23] Cong Liu，Chuanfeng Zhou，Fu Gao，et al. MiR-34a in age and tissue related radio-sensitivity and serum miR-34a as a novel indicator of radiation injury[J]. Int J Biol Sci，2011，7 (2)：221–233. [24] Lu J，Getz G，Miska EA，et al. MicroRNA expression profiles classify human cancers[J]. Nature， 2005，435 (7043)：834–838. [25] Gallardo E，Navarro A，Vinolas N，et al. MiR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer[J]. Carcinogenesis，2009，30 (11)：1903–1909. [26] Wiggins JF，Ruffino L，Kelnar K，et al. Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34[J]. Cancer Res，2010，70 (14)：5923–5930. |
